Genfit
Records under this name other than the patents Genfit holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 58 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,400,078 | Methods of Treatment for Cholestatic and Fibrotic Diseases Lapsed on the fee record Ended Aug 2, 2026 · High confidence | Lapsed on the fee record | Ended Aug 2, 2026 | High confidence |
| US 11,191,749 | Pharmaceutical compositions for combination therapy Lapsed on the fee record Ended Dec 7, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 7, 2025 | From the USPTO record |
| US 7,547,729 | 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same Term ended Term ended Oct 13, 2025 · From the USPTO record | Term ended | Term ended Oct 13, 2025 | From the USPTO record |
| US 8,461,183 | PPAR agonist compounds, preparation and uses Lapsed on the fee record Ended Jun 11, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2025 | From the USPTO record |
| US 7,632,870 | Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Term ended Term ended May 4, 2025 · From the USPTO record | Term ended | Term ended May 4, 2025 | From the USPTO record |
| US 9,586,963 | Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists Lapsed on the fee record Ended Mar 7, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 7, 2025 | From the USPTO record |
| US 10,799,510 | Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists Lapsed on the fee record Ended Oct 13, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 13, 2024 | From the USPTO record |
| US 7,385,082 | Preparation of 1,3-diphenylprop-2-en-1-one derivatives Term ended Term ended Sep 9, 2024 · From the USPTO record | Term ended | Term ended Sep 9, 2024 | From the USPTO record |
| US 8,188,148 | Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof Lapsed on the fee record Ended May 29, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 29, 2024 | From the USPTO record |
| US 8,088,819 | Derivatives of substituted 3-phenyl-1-(phenylthienyl)propan-1-ones and of 3-phenyl-1-(phenylfuranyl) propan-1-ones, preparation and use Lapsed on the fee record Ended Jan 3, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 3, 2024 | From the USPTO record |